Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - THERALINK TECHNOLOGIES, INC. | Financial_Report.xls |
10-K - ANNUAL REPORT - THERALINK TECHNOLOGIES, INC. | form10k.htm |
EX-32.2 - CERTIFICATION - THERALINK TECHNOLOGIES, INC. | exhibit32-2.htm |
EX-31.1 - CERTIFICATION - THERALINK TECHNOLOGIES, INC. | exhibit31-1.htm |
EX-31.2 - CERTIFICATION - THERALINK TECHNOLOGIES, INC. | exhibit31-2.htm |
EX-10.40 - ASSET PURCHASE AGREEMENT - THERALINK TECHNOLOGIES, INC. | exhibit10-40.htm |
EX-10.41 - CO-PROMOTION AGREEMENT - THERALINK TECHNOLOGIES, INC. | exhibit10-41.htm |
EX-10.43 - PROMISSORY NOTE AMENDMENT - THERALINK TECHNOLOGIES, INC. | exhibit10-43.htm |
EX-10.42 - PROMISSORY NOTE AMENDMENT - THERALINK TECHNOLOGIES, INC. | exhibit10-42.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
The undersigned, Cameron Durrant, hereby certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that
1. |
the annual report on Form 10-K of PediatRx Inc. for the period ended February 29, 2012 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. |
the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of PediatRx Inc. |
May 18, 2012
/s/Cameron Durrant | |
Cameron Durrant | |
President, Chief Executive Officer and Director | |
(Principal Executive Officer) |